Skip to content

Kyverna Therapeutics, Inc. KYTX Change in Other Assets

Change in Other Assets at other companies

Climb Bio, Inc. logo
Climb Bio, Inc.CLYM
$0-100%
Artiva Biotherapeutics, Inc. logo
Artiva Biotherapeutics, Inc.ARTV
$40K+229%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$1.47M-54.9%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$2.33M+919%
Vor Biopharma logo
Vor BiopharmaVOR
$6.36M+2,653%
Allogene Therapeutics logo
Allogene TherapeuticsALLO
-$84K+80.2%

Other financials

Income statement

See full
Operating income-$41.4M+12.7%
Net income-$39.7M+11.0%
EPS (diluted)-$0.66+35.9%

Balance sheet

See full
Cash & equivalents$32.2M-43.4%
Total debt$9.2M+32.1%
Total equity$195.6M-12.7%
Total assets$257.0M-1.4%

Cash flow

See full
Operating cash flow-$41.6M+7.4%
CapEx$2.0K-98.0%
Free cash flow-$33.5M+10.8%

Valuation

See full
Market cap$498.52M+276%
Enterprise value$475.49M+475%

Returns & leverage

See full
Return on equity-74.5%+74.4pp
Debt / equity0.0×
Current ratio8.1×+0.7×

Where this comes from

Reported directly by Kyverna Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentAssets.

The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kyverna Therapeutics, Inc.'s change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kyverna Therapeutics, Inc.'s change in other assets?
Kyverna Therapeutics, Inc. (KYTX) reported change in other assets of $5K in Q1 2026.
How has Kyverna Therapeutics, Inc.'s change in other assets changed year-over-year?
Kyverna Therapeutics, Inc.'s change in other assets decreased by 99.0% year-over-year, from $515K to $5K.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.